Patents by Inventor Barbara Christine Potts

Barbara Christine Potts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteasome inhibitors
    Patent number: 8389564
    Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: March 5, 2013
    Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
  • PROTEASOME INHIBITORS
    Publication number: 20120270919
    Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.
    Type: Application
    Filed: May 14, 2012
    Publication date: October 25, 2012
    Applicant: Nereus Pharmaceuticals, Inc.
    Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
  • Proteasome inhibitors
    Patent number: 8227503
    Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: July 24, 2012
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
  • Total synthesis of salinosporamide A and analogs thereof
    Patent number: 8067616
    Abstract: The present invention relates to certain compounds and to methods for the preparation of certain compounds that can be used in the fields of chemistry and medicine. Specifically, described herein are methods for the preparation of various compounds and intermediates, and the compounds and intermediates themselves. More specifically, described herein are methods for synthesizing Salinosporamide A and its analogs from a compound of formula (V).
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: November 29, 2011
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Taotao Ling, Venkata Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur
  • PROTEASOME INHIBITORS
    Publication number: 20110172285
    Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.
    Type: Application
    Filed: March 21, 2011
    Publication date: July 14, 2011
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
  • TOTAL SYNTHESIS OF SALINOSPORAMIDE A AND ANALOGS THEREOF
    Publication number: 20110105762
    Abstract: The present invention relates to certain compounds and to methods for the preparation of certain compounds that can be used in the fields of chemistry and medicine. Specifically, described herein are methods for the preparation of various compounds and intermediates, and the compounds and intermediates themselves. More specifically, described herein are methods for synthesizing Salinosporamide A and its analogs from a compound of formula (V).
    Type: Application
    Filed: October 27, 2010
    Publication date: May 5, 2011
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventors: Taotao Ling, Venkata Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur
  • Proteasome inhibitors
    Patent number: 7910616
    Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: March 22, 2011
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
  • Total synthesis of salinosporamide A and analogs thereof
    Patent number: 7842814
    Abstract: The present invention relates to certain compounds and to methods for the preparation of certain compounds that can be used in the fields of chemistry and medicine. Specifically, described herein are methods for the preparation of various compounds and intermediates, and the compounds and intermediates themselves. More specifically, described herein are methods for synthesizing Salinosporamide A and its analogs from a compound of formula (V).
    Type: Grant
    Filed: April 6, 2007
    Date of Patent: November 30, 2010
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Taotao Ling, Venkata Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur
  • PROTEASOME INHIBITORS
    Publication number: 20090298906
    Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.
    Type: Application
    Filed: May 12, 2009
    Publication date: December 3, 2009
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
  • Methods of using [3.2.0] heterocyclic compounds and analogs thereof
    Patent number: 7579371
    Abstract: Disclosed are methods of treating cancer comprising administering to the animal, a therapeutically effective amount of a heterocyclic compound of Formula VI. The animal is a mammal, preferably a human or a rodent.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: August 25, 2009
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Michael Palladino, Barbara Christine Potts, Venkata Rami Reddy Macherla, Saskia Theodora Cornelia Neuteboom
  • METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF
    Publication number: 20090182027
    Abstract: Disclosed are methods of treating cancer, inflammatory conditions, and/or infectious disease in an animal comprising: administering to the animal, a therapeutically effective amount of a heterocyclic compound. The animal is a mammal, preferably a human or a rodent.
    Type: Application
    Filed: June 10, 2008
    Publication date: July 16, 2009
    Applicant: Nereus Pharmaceuticals, Inc.
    Inventors: Michael Palladino, Saskia Theodora Cornelia Neuteboom, Venkata Rami Reddy Macherla, Barbara Christine Potts
  • [3.2.0] Heterocyclic compounds and methods of using the same
    Patent number: 7544814
    Abstract: Compounds of Formulae I-VI and derivatives thereof having anti-cancer, anti-inflammatory, and anti-microbial properties and to compositions that include one or more of compounds and their derivatives or analogs having anti-cancer, anti-inflammatory and anti-microbial properties are disclosed. Pharmaceutical compositions comprising such compounds and methods of treating cancer, inflammatory conditions, and microbial infections with the disclosed compounds or the disclosed pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: June 9, 2009
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Barbara Christine Potts, Venkat Macherla, Scott Sherman Mitchell, Ram Rao Manam, Katherine A. McArthur, Kin Sing Lam, Saskia Neuteboom, Ta-Hsiang Chao, Benjamin Nicholson, Cheryl L. Billstrom
  • [3.2.0] Heterocyclic compounds and methods of using the same
    Patent number: 7276530
    Abstract: Compounds of Formulae I-VI and derivatives thereof having anti-cancer, anti-inflammatory, and anti-microbial properties and to compositions that include one or more of compounds and their derivatives or analogs having anti-cancer, anti-inflammatory and anti-microbial properties are disclosed. Pharmaceutical compositions comprising such compounds and methods of treating cancer, inflammatory conditions, and microbial infections with the disclosed compounds or the disclosed pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: October 2, 2007
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Barbara Christine Potts, Venkat Macherla, Scott Sherman Mitchell, Ram Rao Manam, Katherine Reed, Kin Sing Lam, Saskia Neuteboom, Ta-Hsiang Chao, Benjamin Nicholson, Cheryl Billstrom